A Schmitt-Graeff
Overview
Explore the profile of A Schmitt-Graeff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
598
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nashan D, Friedrich C, Geissler E, Schmitt-Graeff A, Klein F, Meiss F
Hautarzt
. 2018 Jun;
69(12):1014-1020.
PMID: 29881891
Background: In addition to a broad and clinically diverse spectrum of known primary cutaneous lymphomas, for which an incidence of 1-3:100,000 is postulated, each year further entities are specified and...
2.
Stickel N, Hanke K, Marschner D, Prinz G, Kohler M, Melchinger W, et al.
Leukemia
. 2017 May;
31(12):2732-2741.
PMID: 28484267
Acute Graft-versus-host disease (GVHD) is a major immunological complication after allogeneic hematopoietic cell transplantation and a better understanding of the molecular regulation of the disease could help to develop novel...
3.
Elgizouli M, Lowe D, Speckmann C, Schubert D, Hulsdunker J, Eskandarian Z, et al.
Clin Exp Immunol
. 2015 Oct;
183(2):221-9.
PMID: 26437962
The gene PIK3CD codes for the catalytic subunit of phosphoinositide 3-kinase δ (PI3Kδ), and is expressed solely in leucocytes. Activating mutations of PIK3CD have been described to cause an autosomal...
4.
Hoermann G, Cerny-Reiterer S, Sadovnik I, Mullauer L, Bilban M, Groger M, et al.
Allergy
. 2013 Apr;
68(6):713-23.
PMID: 23621172
Background: Chronic eosinophilic leukemia (CEL) is a myeloproliferative neoplasm characterized by expansion of neoplastic eosinophils, tissue infiltration, and organ damage. In a subset of these patients, the FIP1L1/PDGFRA (F/P) oncoprotein...
5.
Hasselblatt P, Drognitz K, Potthoff K, Bertz H, Kruis W, Schmidt C, et al.
Aliment Pharmacol Ther
. 2012 Sep;
36(8):725-35.
PMID: 22937722
Background: Despite advances in immunosuppressive therapy, up to 10% of patients with severe Crohn's disease (CD) remain refractory to conventional treatment. Limited evidence from pilot trials suggests that high-dose immunosuppression...
6.
Kreisel W, Dahlberg M, Bertz H, Harder J, Potthoff K, Deibert P, et al.
Bone Marrow Transplant
. 2011 Jun;
47(3):430-8.
PMID: 21706064
Diagnosis of acute intestinal GVHD (aGVHD) following allogeneic hematopoietic cell transplantation is based on clinical symptoms and histological lesions. This retrospective analysis aimed to validate the 'Freiburg Criteria' for the...
7.
Chevalier N, Udi J, Sigler M, Wolf M, Heinz J, Schmitt-Graeff A, et al.
Eur J Haematol
. 2010 Jun;
85(4):368-9.
PMID: 20561035
No abstract available.
8.
Houet L, Moller I, Engelhardt M, Kohler G, Schmidt H, Herchenbach D, et al.
Bone Marrow Transplant
. 2009 Sep;
45(4):793-5.
PMID: 19718066
No abstract available.
9.
Pfeiffer M, Hartmann T, Leick M, Catusse J, Schmitt-Graeff A, Burger M
Br J Cancer
. 2009 May;
100(12):1949-56.
PMID: 19455144
Small cell lung cancer (SCLC) is an aggressive, rapidly metastasising tumour. Previously, we demonstrated the influence of CXCL12-CXCR4 interaction on processes involved in metastasis and chemoresistance in SCLC. We show...
10.
Kratz C, Niemeyer C, Juttner E, Kartal M, Weninger A, Schmitt-Graeff A, et al.
Leukemia
. 2007 Nov;
22(5):1078-80.
PMID: 18007577
No abstract available.